COVID-19 and shielding: experiences of UK patients with lupus and related diseases

OBJECTIVE: The shielding guidance in the UK for the clinically extremely vulnerable (CEV) commenced on 23 March 2020 in response to the coronavirus disease 2019 (COVID-19) pandemic. The purpose of this study was to explore the impact of the pandemic and shielding on patients with lupus and related s...

Descripción completa

Detalles Bibliográficos
Autores principales: Sloan, Melanie, Gordon, Caroline, Lever, Elliott, Harwood, Rupert, Bosley, Michael A, Pilling, Mark, Brimicombe, James, Naughton, Felix, Blane, Moira, Walia, Chanpreet, D’Cruz, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7928599/
https://www.ncbi.nlm.nih.gov/pubmed/33728396
http://dx.doi.org/10.1093/rap/rkab003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7928599/
https://www.ncbi.nlm.nih.gov/pubmed/33728396
http://dx.doi.org/10.1093/rap/rkab003

Ejemplares similares